Infection Prevention and Control




Multi-resistant pathogens cause increases in healthcare costs due to the demand for more expensive drugs and prolonged hospital stays. Multi-resistant drugs are responsible for increased morbidity and mortality of patients admitted to hospitals. These hospital-acquired infections affect the most fragile patients in intensive care units; oncology and neonatology, which often result in high mortality.